Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
no adverse event; patient ran out of medication; missed dose; This spontaneous report was received from a physician and refers to multiple patients of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. From 29-Jan-2025 to 19-feb-2025 (exact dates were unknown), the patients had missed doses of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), for prophylaxis (schemes, doses, routes of administration, anatomical locations, lot numbers, and expiration dates were not reported) due to a delay of shipment (missed dose) (patient ran out of medication). No other information was known or provided.; Reporter's Comments: